A case of nonfunctioning islet cell tumor with hyperammonemia and hyperamylasemia
Autor: | Takuo Shinozaki, Uichiro Matsuoka, Takashi Kanematsu, Nobuo Tsuda, Satoshi Yamaguchi, Shigetoshi Matsuo |
---|---|
Rok vydání: | 1994 |
Předmět: |
geography
medicine.medical_specialty geography.geographical_feature_category Hepatology business.industry medicine.medical_treatment Splenectomy Hyperammonemia medicine.disease Islet Gastroenterology Abdominal mass Lactulose Endocrinology Pancreatic tumor Internal medicine medicine Hyperamylasemia Surgery medicine.symptom business Pancreatic hormone medicine.drug |
Zdroj: | Journal of Hepato-Biliary-Pancreatic Surgery. 1:595-599 |
ISSN: | 1436-0691 0944-1166 |
DOI: | 10.1007/bf01211927 |
Popis: | A case of nonfunctioning islet cell tumor with hyperammonemia and hyperamylasemia is reported. A 67-year-old female was admitted in an unconsciousness state, with a large abdominal mass about 10×10 cm in size. Hyperammonemia and hyperamylasemia were evident. Blood sugar levels, electroencephalogram (EEG), and brain scan were normal. After admission, lactulose and gabexate mesilate were administered for the hyperammonemia and hyperamylasemia. Serum ammonia levels returned to the normal range within 2 weeks, but serum amylase levels failed to decrease. Results of the oral glucose tolerance test were normal. A contrast computed tomographic (CT) scan revealed a tumor with a homogeneous enhancement pattern. Angiography demonstrated a hypervascular pancreatic tumor. Distal pancreatectomy with splenectomy was performed on the basis of a preoperative diagnosis of pancreatic tumor with extrapancreatic growth. Histological examination showed nonfunctioning islet cell tumor, with evidence of vascular invasion of tumor cells. Production of pancreatic hormones was not noted. The patient promptly returned to normal consciousness, and no elevation of ammonia or amylase was observed other than an incidental elevation of the latter due to pseudocyst formation. The hyperamylasemia was obviously related to tumor growth, and the pancreatic tumor itself may have contributed to the hyperammonemia. |
Databáze: | OpenAIRE |
Externí odkaz: |